drugset / Trial / NCT00907335

A Study of Acne Treatment in Children Ages 9 to 11

NCT00907335

Phase 2 Completed 110 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to determine if using Retin-A Micro 0.04% as facial acne treatment in patients ages 9 to 11 is safe and efficacious.

Timeline

Start
2009-02
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tretinoin Small molecule 0.04 %

Indications